Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice

NeuroReport

Volumn 9, Issue 15, 1998, Pages 3415-3419

  Guan, Xiao Ming ^a   Yu, Hong ^a   Trumbauer, Myrna ^a   Frazier, Easter ^a   Van Der Ploeg, Lex H T ^a   Chen, Howard ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Agouti related protein; Diet induced obesity; Dorsomedial hypothalamic nucleus; Expression; mRNA; Neuropeptide Y; Pro opiomelanocortin

Indexed keywords

NEUROPEPTIDE Y; PROOPIOMELANOCORTIN;

ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY FAT; CONTROLLED STUDY; ENERGY EXPENDITURE; GENE INDUCTION; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032569615     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199810260-00015     Document Type: Article

References (26)

1. Bray GA. Mechanisms for development of genetic, hypothalamic, and dietary obesity. In: Bray GA and Ryan DH, eds. Pennington Center Nutrition Series : Molecular and Genetic Aspects of Obesity. Baton Rouge: Louisiana State University Press, 1996: 3-66.
2. West D, York B, Goudey-Lefevre J et al. Genetics and Physiology of Dietary Obesity in the Mouse. In: Bray GA and Ryan DH, eds. Molecular and Genetics Aspects of Obesity. Baton Rouge: Louisana State University Press, 1996: 100-119.
3. West DB, Boozer CN, Moody DL et al. Am J Physiol 262, R1025-R1032 (1992).
4. Schemmel R, Mickelsen O and Gill JL. J Nutr 100, 1041-1048 (1970).
5. Frederich RC, Hamann A, Andersen S et al. Nature Med 1, 1311-1314 (1995).
6. Maffei M, Halaas J, Ravussin E et al. Nature Med 1, 1155-1161 (1995)
7. Widdowson PS, Upton R, Buckingham R et al. Diabetes 46, 1782-1785 (1997).
8. Aclafani A. Ann NY Acad Sci 575, 281-289 (1989).
9. Stanley BG, Magdalin W, Seirafi A et al. Peptides 13, 381-387 (1992).
10. Fan W, Boston BA, Kesterson RA et al. Nature 385, 165-168 (1997).
11. Kesterson RA, Huszar D, Lynch CA et al. Mol Endocrinol 11, 630-637 (1997).
12. Schwartz MW, Seeley RJ, Woods SC et al. Diabetes 49, 2119-2123 (1997).
13. Beck B, Stricker-Krongrad A, Burlet A et al. Brain Res Bull 34, 85-91 (1994).
14. Beck B, Stricker-Krongrad A, Burlet A et al. Neuropeptides 17, 197-203 (1990).
15. Levin BE and Dunn Meynell AA. Am J Physiol 272, R1365-R1370 (1997).
16. Guan X-M, Yu H, Palyha OC et al. Mol Brain Res 48, 23-29 (1997).
17. Guan X-M, Yu H and Van der Ploeg LHT, Mol Brain Res 59, 273-279 (1998).
18. Frankish HM, Dryden S, Hopkin D et al. Peptides 16, 757-771 (1995).
19. Smith MS. Endocrinology 133, 1258-1265 (1993).
20. Bernardis LL. J Neural Transm 33, 1-10 (1972).
21. Thompson RH, Canteras NS and Swanson LW. J Comp Neurol 376, 143-173 (1996).
22. Canteras NS, Simerly RB and Swanson LW. J Comp Neurol 348, 41-79 (1994)
23. Schwartz MW, Baskin DG, Bukowski TR et al. Diabetes 45, 531-535 (1996).
24. Ollmann MM, Wilson BD, Yang Y-K et al. Science 278, 135-138 (1997).
25. Graham M, Shutter JR, Sarmiento U et al. Nature Genet 17, 273-274 (1997).
26. Bultman SJ, Michaud EJ and Woychik RP. Cell 71, 1195-1204 (1992).